Interestingly, PD-L1 expression (≥1%) by tumor cells did not predict treatment response significantly (9/28 of responders, 1/12 of non-responders; p = 0.2307), in contrast to its expression by immune cells. The gene discussed is CD274; the disease is neoplasm.